Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Acquisitions (2021)

Historic Acquisitions for Beam Therapeutics (BEAM) over the last 1 years, with Q1 2021 value amounting to $620000.0.

  • Beam Therapeutics' Acquisitions changed N/A to $620000.0 in Q1 2021 from the same period last year, while for Dec 2021 it was $620000.0, marking a year-over-year change of. This contributed to the annual value of $620000.0 for FY2021, which is N/A changed from last year.
  • Latest data reveals that Beam Therapeutics reported Acquisitions of $620000.0 as of Q1 2021.
  • In the past 5 years, Beam Therapeutics' Acquisitions ranged from a high of $620000.0 in Q1 2021 and a low of $620000.0 during Q1 2021